w66国际·利来(中国)最给力的老牌
About Us
About Sino Biopharm
Board of Directors
Senior Management
R&D
R&D Team
Products
Product List
Sustainability
ESG Governance
ESG Management Practices
ESG Reports
Investors
Information Disclosure
Corporate Governance
Presentation
Investor FAQ
Notices
News
Press Releases
Contact
CN
EN
Investors
Home
>
Investors
>
Information Disclosure
Information Disclosure
Corporate Governance
Presentation
Investor FAQ
Notices
Information Disclosure
2024 ANNUAL REPORT
2025.04.29
GENERAL MANDATES TO ISSUE AND BUY BACK SHARES; RE-ELECTION OF DIRECTORS; ADOPTION OF THE NEW ARTICLES; AND NOTICE OF ANNUAL GENERAL MEETING
2025.04.29
NOTICE OF ANNUAL GENERAL MEETING
2025.04.29
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING (OR ANY ADJOURNMENT OR POSTPONEMENT THEREOF)
2025.04.29
NOTIFICATION LETTER AND REPLY FORM FOR REGISTERED SHAREHOLDERS
2025.04.29
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS
2025.04.29
2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
2025.04.29
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR MARKETING OF PENPULIMAB INJECTION BY THE US FDA
2025.04.25
1
2
3
4
5
6
...
53
尾页
下一页